What is the recommended concentration for this antibody in ELISA applications?

For ELISA applications, a typical starting dilution of the Anti-HAV VP1 Recombinant Antibody (K3-4C8) would be 1:500 to 1:1000. Optimal concentrations, however, can differ and should be ascertained through titration tests according to the assay circumstances.

Is this antibody species-specific, and if so, what does it target?

This antibody is indeed quite selective. The Hepatitis A Virus (HAV) VP1 protein is a significant capsid component used in virus characterisation and research, and it is the target of the Anti-HAV VP1 Recombinant Antibody (K3-4C8).

Are there any compatibility issues with common lab reagents?

There are no known problems with standard laboratory reagents and compatibility. It is, nevertheless, advisable to avoid severe conditions or solvents that could denature the antibody or target protein.

Anti-HAV VP1 Recombinant Antibody (K3-4C8)

Products

Recombinant Antibodies
Functional Antibodies
Anti-Drug Antibodies
- Anti-Biologic Drug Antibodies
- Anti-Small Molecule Drug Antibodies
AbPlus
Formats
Research Area
- Neuroscience Antibodies
- Cancer Stem Cell Biomarker Specific Antibodies
Engineered Antibodies
AbProcessing
- Antibody Labeling Kits
- Antibody Purification & Characterization related Products
Tetramers
Proteolytic Enzymes
Antibody-like Scaffold Proteins
Therapeutic Proteins
Soluble T Cell Receptors

Services

High Throughput Antibody Production
Custom Antibody Production & QC
Engineered Antibody Production & QC
Antibody Derivative Development
Bispecific Antibody Development
Antibody-Drug Conjugate Development
Glycoprotein Glycosylation Analysis
BCR Production & QC
Soluble TCR Production & QC

The Science of Biosimilars

Physicochemical Characterization
Biological Activity Characterization
Stability Characterization
In Vivo Non-Clinical Studies
Statistical Equivalence Analysis

One-Stop CDMO Solutions

Plasmid CDMO Solutions
- Strains & Strain Bank Establishment
- Plasmid Process Development
Antibody CDMO Solutions

Research Area

Cancer Biomarkers
Cancer Immunology
Oncoproteins
Signal Transduction in Cancer
Cell Cycle
Cell Metabolism
Apoptosis
Autophagy

Supports

FAQs
Resources
Downloads
Webinars

Company

About Us
Contact Us
Distributors
Careers
Scholarship Program
Online Inquiry
Newsletters
We Want Your Feedback!
Events

Creative Biolabs provides state-of-the-art biosimilar development and biosimilar biosafety testing services for biologics. We tailor solutions to best suit your technical and budget requirements.

Creative Biolabs distributes biosimilars development with advanced technology platforms and professionals. We are seeking partners to develop biosimilars together and accelerate the expansion of our biosimilar portfolio.

Creative Biolabs is committed to accelerating the design, engineering, validation, and biomanufacturing of engineered antibody products.

Creative Biolabs is bringing our expertise to biosimilar development programs including recombinant antibody and protein biosimilars. We are seeking partnerships with companies who are interested in co-developing biosimilars.

Creative Biolabs offers a broad range of services for development and production of antibodies and other reagents. High-quality products enable you to develop innovative solutions to advance scientific discovery.

Creative Biolabs has built integrated service platforms that cover the entire process from early-stage development to large-scale non-GMP commercialization. Seamless transition from production to downstream analysis process advances your discovery.

Creative Biolabs introduces background and research progress across a range of research areas, provides a comprehensive list of targets for therapeutic antibody discovery, and presents recommended antibody products with tested data-supported.

Creative Biolabs aims to provide you with a reliable source of antibodies and support you with our experience and expertise for your research.

Creative Biolabs is the leading supplier of antibodies for life science research. We have established ourselves as a developer and manufacturer of high-quality antibodies and other detection products.

Product Gene Keyword

Popular Searches: Recombinant Antibody MHC Tetramer T cell Receptor Scaffold Protein

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

See other products for "HAV VP1"

CAT	Product Name	Application	Type
MRO-539CQ	Recombinant Mouse Anti-HAV VP1 Antibody (MRO-539CQ)	ELISA, WB	Mouse antibody
MRO-540CQ	Recombinant Mouse Anti-HAV VP1 Antibody (MRO-540CQ)	ELISA, WB	Mouse antibody
MRO-541CQ	Recombinant Mouse Anti-HAV VP1 Antibody (MRO-541CQ)	ELISA, WB	Mouse antibody
VS-0923-FY85	Recombinant Mouse Anti-HAV VP1 Antibody (VS-0923-FY85)	ELISA, WB	Mouse IgG1

CAT

Product Name

Application

Type

MRO-539CQ

Recombinant Mouse Anti-HAV VP1 Antibody (MRO-539CQ)

ELISA, WB

Mouse antibody

MRO-540CQ

Recombinant Mouse Anti-HAV VP1 Antibody (MRO-540CQ)

ELISA, WB

Mouse antibody

MRO-541CQ

Recombinant Mouse Anti-HAV VP1 Antibody (MRO-541CQ)

ELISA, WB

Mouse antibody

VS-0923-FY85

Recombinant Mouse Anti-HAV VP1 Antibody (VS-0923-FY85)

ELISA, WB

Mouse IgG1

Customer Reviews and Q&As

CAT	Product Name	Application	Type
MRO-539LC	Anti-HAV VP1 Recombinant Antibody (K2-4F2)	ELISA	Human antibody
MRO-538LC-S(P)	Anti-HAV VP1 Recombinant Antibody scFv Fragment (K3-4C8)	ELISA	Human antibody
MRO-539LC-S(P)	Anti-HAV VP1 Recombinant Antibody scFv Fragment (K2-4F2)	ELISA	Human antibody
MRO-538LC-F(E)	Anti-HAV VP1 Recombinant Antibody Fab Fragment (K3-4C8)	ELISA	Human antibody
MRO-539LC-F(E)	Anti-HAV VP1 Recombinant Antibody Fab Fragment (K2-4F2)	ELISA	Human antibody

CAT	Product Name	Application	Type
EPAF-0313CQ	Recombinant Mouse Anti-HAV VP1 Antibody (4F2)	ELISA, Inhib	IgG2a
EPAF-0314CQ	Recombinant Mouse Anti-HAV VP1 Antibody (4C8)	Inhib	IgG2a

Customer Review Q&As

Reliable in ELISA

For several months, we have been utilizing Anti-HAV VP1 Recombinant Antibody (K3-4C8) in our ELISA configurations. Its exceptional consistency and dependability in identifying HAV VP1 are noteworthy. Strongly advised for use in virology labs.

Excellent Specificity

The antibody's specificity has been exceptionally demonstrated in our Western blot tests. It is a top-notch product for HAV study because of the clear bands and lack of non-specific binding.

Great for Protein Quantification

We have successfully used this antibody to use ELISA to quantify HAV VP1 in a variety of sample types. Even with low-abundance proteins, it offers unparalleled sensitivity and accuracy.

Q 1: What is the recommended concentration for this antibody in ELISA applications?
A: For ELISA applications, a typical starting dilution of the Anti-HAV VP1 Recombinant Antibody (K3-4C8) would be 1:500 to 1:1000. Optimal concentrations, however, can differ and should be ascertained through titration tests according to the assay circumstances.
Q 2: Is this antibody species-specific, and if so, what does it target?
A: This antibody is indeed quite selective. The Hepatitis A Virus (HAV) VP1 protein is a significant capsid component used in virus characterisation and research, and it is the target of the Anti-HAV VP1 Recombinant Antibody (K3-4C8).
Q 3: Are there any compatibility issues with common lab reagents?
A: There are no known problems with standard laboratory reagents and compatibility. It is, nevertheless, advisable to avoid severe conditions or solvents that could denature the antibody or target protein.

View the frequently asked questions answered by Creative Biolabs Support.